Clinical Trials Logo
  1. Home
  2. Candida Infection
  3. NCT05720728

Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients — 2419  

Candida Infection Clinical Trial

Official title:
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients

Clinical Trial Summary

Bloodstream infections due to Candida spp remain a serious medical challenge because of their high incidence and poor outcome. Diagnosis and monitoring of patients are still problematic, hindering efficient clinical management of the disease. The invastigators propose here to perform a retrospective study in a clinically well-characterized candidemic patient, with the goal of recognizing host immunological factors and virulence-associated fungal molecules relevant in the onset and evolution of infection. The researchers' ultimate goal is to identify new diagnostic and/or prognostic benchmarks useful in clinical settings. By combining serologic and immunologic expertise with clinical expertise, the research team has real potential to generate new markers of host pathogenesis and immune response in candidemia and to inform prospective clinical trials to control this terrible disease

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05720728
Study type Observational
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact
Status Completed
Phase
Start date May 14, 2019
Completion date February 17, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03641131 - Ampholipad Real-World Data in Taiwan
Completed NCT03203551 - Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. N/A
Not yet recruiting NCT03666195 - The Anti-microbial Effect of Titanium Dioxide Nano Particles in Complete Dentures Made for Edentulous Patients N/A
Active, not recruiting NCT06146504 - Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement N/A
Completed NCT01495039 - Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients Phase 4
Completed NCT04935463 - Mucormycosis in COVID-19
Completed NCT03140748 - Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation N/A
Completed NCT01743690 - The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus N/A
Completed NCT03630770 - Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida Phase 1
Recruiting NCT05908682 - Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Not yet recruiting NCT05761197 - Oropharyngeal Candidiasis (OPC) and S-ECC
Recruiting NCT05225493 - HIV Indicator Diseases in Hospital and Primary Care
Completed NCT04148287 - An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris Phase 2